Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19-Reference-Cited by-同舟云学术

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19

Published:2021-04-02 Issue:3 Volume:4 Page:1124-1135
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Hu Xin¹^ORCID,Shrimp Jonathan H.¹,Guo Hui¹,Xu Miao¹,Chen Catherine Z.¹,Zhu Wei¹,Zakharov Alexey V.¹^ORCID,Jain Sankalp¹,Shinn Paul¹,Simeonov Anton¹,Hall Matthew D.¹^ORCID,Shen Min¹

Affiliation:

1. National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States

Funder

National Center for Advancing Translational Sciences

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00221

Reference51 articles.

1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin